Tirzepatide: Research Peptide Overview

Tirzepatide is a synthetic 39-amino-acid, lipid-conjugated peptide (CAS 2023788-19-2) engineered as a dual agonist of the GIP and GLP-1 receptors, handled in laboratories as a research-grade lyophilized material.
What it is
Tirzepatide is a synthetic single-chain polypeptide belonging to the class of incretin-mimetic peptides, and is classified within the GLP-1 category of research compounds as a dual GIP/GLP-1 receptor agonist. It is catalogued under CAS number 2023788-19-2 and carries the molecular formula C225H348N48O68 with an average molecular weight of 4813.45 g/mol. As a structurally engineered analog, it is investigated in in-vitro incretin-receptor pharmacology and nutrient-signaling research models. Structurally, tirzepatide is a 39-residue peptide (39 amino acids) built on a modified incretin backbone. The sequence incorporates the non-proteinogenic residue 2-aminoisobutyric acid (Aib) at position 2 and in the position-13 region, substitutions that increase conformational rigidity and confer resistance to enzymatic degradation relative to native incretins. The lysine at position 20 is covalently conjugated to a C20 fatty-diacid moiety through a linker composed of a γ-glutamate spacer and two AEEA (8-amino-3,6-dioxaoctanoic acid) units, and the chain terminates in a C-terminal amide. This lipidation architecture is a defining feature of the molecule and is the subject of structure-activity study, as the fatty-acid tail is understood in research settings to mediate reversible association with serum albumin, extending the peptide's circulating profile in experimental systems. Within a strictly research context, tirzepatide is used as a reference agonist for probing GIP and GLP-1 receptor binding, receptor-complex conformation, and downstream cyclic-AMP signaling in cell-based assays.
Stability and storage in the literature
In its lyophilized form, tirzepatide is stable for extended periods when stored sealed, protected from light and moisture, and kept frozen; short intervals at refrigerated or ambient temperature during shipping and handling are generally tolerated by the dry powder. Handling material at cold temperatures and limiting time at room temperature helps preserve chromatographic purity over the working period.
Frequently asked questions
What is tirzepatide?
Tirzepatide is a synthetic 39-amino-acid peptide (CAS 2023788-19-2) classified as a dual GIP/GLP-1 receptor agonist. It is, handled in laboratories as a lyophilized research-grade material and is not intended for human or veterinary use.
What are its molecular formula and weight?
Tirzepatide has the molecular formula C225H348N48O68 and an average molecular weight of 4813.45 g/mol. It comprises 39 amino acid residues, including Aib substitutions and a C20 fatty-diacid conjugated at Lys20 via a γGlu-(AEEA)2 linker, with a C-terminal amide.
What makes tirzepatide structurally distinctive?
Its defining feature is a lipidation architecture: the lysine at position 20 is conjugated to a C20 diacid through a γ-glutamate spacer and two AEEA units. Combined with Aib residues that rigidify the backbone, this gives the peptide amphipathic character studied in structure-activity research.
For laboratory research use only. Products sold by California Standard Peptides are not drugs, foods, supplements or cosmetics and are not for human or veterinary use. This article summarises published literature; it is not medical advice and not a usage guide.